Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2022

Supplementary Prospectus

24 November 2022 by Audrey Thomson

Supplementary Prospectus

Categories 2022, ASX Announcements

Rights Issue Closed

24 November 2022 by Audrey Thomson

Rights Issue Closed

Categories 2022, ASX Announcements

R&D Tax Incentive

18 November 2022 by Audrey Thomson

R&D Tax Incentive

Categories 2022, ASX Announcements

Results of Annual General Meeting

16 November 2022 by Audrey Thomson

Results of Annual General Meeting

Categories 2022, ASX Announcements

Presentation to Investors

11 November 2022 by Audrey Thomson

Presentation to Investors

Categories 2022, ASX Announcements

Commencement of Rights Trading on ASX

31 October 2022 by Audrey Thomson

Commencement of Rights Trading on ASX

Categories 2022, ASX Announcements

Shareholder Update

31 October 2022 by Audrey Thomson

Shareholder Update

Categories 2022, ASX Announcements

Entitlement Issue Prospectus

27 October 2022 by Audrey Thomson

Entitlement Issue Prospectus

Categories 2022, ASX Announcements

Renounceable Rights Issue to Raise up to $4.2 Million

27 October 2022 by Audrey Thomson

Renounceable Rights Issue to Raise up to $4.2 Million

Categories 2022, ASX Announcements

Proposed Issue of Securities

27 October 2022 by Audrey Thomson

Proposed Issue of Securities

Categories 2022, ASX Announcements
Older posts
Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 24 April 2025        Legal Notices and Privacy
Cleantalk Pixel